Is ERK activation a good biomarker for estradiol and tamoxifen effects?

Cancer Biol Ther. 2007 Jan;6(1):119-20. doi: 10.4161/cbt.6.1.3824.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / pharmacology*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Drug Resistance, Neoplasm*
  • Enzyme Activation
  • Estradiol / pharmacology*
  • Estradiol / therapeutic use
  • Extracellular Signal-Regulated MAP Kinases / analysis*
  • Extracellular Signal-Regulated MAP Kinases / drug effects
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Humans
  • Neoplasms / drug therapy
  • Neoplasms / enzymology*
  • Tamoxifen / pharmacology*
  • Tamoxifen / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Biomarkers
  • Tamoxifen
  • Estradiol
  • Extracellular Signal-Regulated MAP Kinases